Gastroenterology

Some artificial sweeteners may alter the microbiota, affect blood glucose control

A recent study suggests that the microbiome changes in response to human consumption of non-nutritive sweetener may induce glycemic changes in consumers in a personalized manner.

Microbial signature may predict a person’s response to statins

The findings of a new research suggest that different responses to statins can be explained by the variation in the human microbiota.

How some gut microbes worsen chronic pain

The findings of a new research illuminate the link between IBS and gut bacteria, and suggest that histamine is a good target for therapies against the condition.

FMT: challenges and opportunities in IBD clinical trial design

Maria Teresa Abreu (University of Miami, USA) discussed some new strategies to design clinical trials.

Epithelial barrier: the enigmatic roles of Gasdermin B and gut microbiome

Theresa Pizarro, (Case Western Reserve University School of Medicine) discussed the roles of epithelial barrier’s cytokines, gut microbiome and Gasdermin in IBD patients.

Probiotic Supplement Reduces Alcohol Absorption in Small Intestine

Probiotic supplements with ethanol-metabolizing activity may help reduce the disease burden of excessive alcohol consumption.

Microbiota transplant and IBD: what is missing

Sudarshen Paramsothy (University of New South Wales, Australia) discussed the controversials about FMT in IBD patients.

IBD, Multiomics approach could pave the way for new therapies

Herbert Tilg (University Innsbruck, Austria) discussed the relationship between Inflammatory Bowel Diseases and gut microbiome.

How gut bacteria may evolve to become harmful

The findings of a new research show that gut bacteria can become harmful over time by gaining the ability to escape the intestine and persist in other organs where they…

Bacterial signatures in gut and airway may be biomarker for COVID-19 severity

The findings of a new research suggest that changes in the microbial composition of people with COVID-19 could be used as a biomarker of invasion of lung pathogens and dysbiosis…

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top